Sequential therapies for advanced urothelial cancer: Hope meets new challenges
Daniel Herchenhorn, Vinicius Freire, Thamires Oliveira, Juliana Tarouquella - Crit Rev Oncol Hematol. 2021 April
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415)
Fernando C. Maluf, Andre P. Fay, Vinícius Carrera Souza, Fabio A. B. Schutz, Oren Smaletz, Daniel Herchenhorn, Vanessa Fabricio, Rosemarie Gidekel, Eduardo Cronemberger, Murilo Luz, Suelen P. S. Martins, David Queiroz Borges Muniz, Fabio Andre Franke, Fabio Peixoto, Flavio Mavignier Carcano, Andrea Juliana Gomes, Felipe Cruz, Rafaela Gomes, Paulo Ricardo Santos Nunes Filho, Gustavo Werutsky - Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020)
Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic
Andrey Soares, Fabio A Schutz, Diogo Assed Bastos, Denis Jardim, Fernando Sabino Marques Montiero - Oncology (Williston Park). 2020 September
The role of Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?
Fernando Sabino M.Monteiro, Juçara Motta Serafim, Rafaela Gomes de Jesus, Pedro Cavalcante, Gustavo do Vale Gomes, Bruno Hochhegger, Vinicius K.Gonçalves, Laura Von Wallwitz Freitas, Diego H.Roman, Andre Poisl Fay - ScienceDirect. Volume 9, Issue 1, March 2021, Pages 54-59
Advanced Renal Cell Carcinoma (RCC) Management: An Expert Panel Recommendation From the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)
Andrey Soares, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, Diogo Assed Bastos, Denis Leonardo Jardim, André Deeke Sasse, Adriano Gonçalves E Silva, André P Fay, Diogo Augusto Rodrigues da Rosa, Evanius Wierman, Fabio Kater, Fabio A Schutz, Fernando Nunes Galvão de Oliveira, Igor Alexandre Protzner Morbeck, José Augusto Rinck Jr, Karine Martins da Trindade, Manuel Caitano Maia, Vinicius Carrera Souza, Deusdedit Cortez Vieira da Silva Neto, Felipe de Almeida E Paula, Fernando Korkes, Gustavo Franco Carvalhal, Lucas Nogueira, Roni de Carvalho Fernandes, Rodolfo Borges Dos Reis, Wagner Eduardo Matheus, Wilson Francisco Schreiner Busato Jr, Walter Henriques da Costa, Stênio de Cássio Zequi - J Cancer Res Clin Oncol. 2020 July
First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis
Fernando Sabino M Monteiro, Andrey Soares, Márcio Debiasi, Fabio A Schutz, Fernando Cotait Maluf, Diogo Assed Bastos, Andre Sasse, Carolina G S Cauduro, Gabriela Oliveira Mendes, Patricia K Ziegelmann, André P Fay - J Cancer Res Clin Oncol. 2020 July
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgery
Stênio de Cássio Zequi, Walter Henriques da Costa, Fernando Korkes, Rodolfo Borges dos Reis, Wilson Francisco Schreiner Busato, Wagner Eduardo Matheus, Deusdedit Cortez Vieira da Silva Neto, Felipe de Almeida e Paula, Gustavo Franco Carvalhal, Lucas Nogueira, Roni de Carvalho Fernandes, Adriano Gonçalves e Silva, André Deeke Sasse, André P. Fay, Denis Leonardo Jardim, Diogo Assed Bastos, Diogo Augusto Rodrigues da Rosa, Evanius Wierman, Fabio Kater, Fabio A. Schutz, Fernando Cotait Maluf, Fernando Nunes Galvão de Oliveira, Igor Alexandre Protzner Morbeck, José Augusto Rinck, Karine Martins da Trindade, Manuel Caitano Maia, Vinicius Carrera Souza, Fernando Sabino Marques Monteiro, Andrey Soares
Alternative Therapies to Bacillus Calmette-Guérin Shortage for Nonmuscle Invasive Bladder Cancer in Brazil and Other Underdeveloped Countries: Management Considerations
Marcelo Langer Wroclawski, Fabio A. Schutz, Jonathan Doyun Cha, and Andrey Soares
Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs).
Daniel Vargas Almeida, Cleyton Z. Oliveira, Andrey Soares, RODRIGO COUTINHO MARIANO, Denis L Jardim, Diogo Assed Bastos, Fernando C. Maluf, Gustavo Werutsky, Fernando Sabino M Monteiro, Vinicius Carrera Souza, Guillermo de Velasco, Andre P. Fay, Andre Deeke Sasse, Fabio A. B. Schutz ASCO 2019; J Clin Oncol 37, 2019 15_suppl.4579, published online only Full link: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.4579
The LACOG-0415 phase II trial: abirateroneacetate and ADT versus apalutamide versusabiraterone acetate and apalutamide inpatients with advanced prostate cancerwith non-castration testosterone levels
Gustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, Vinicius Carrera Souza, Suelen Patricia dos Santos Martins, Fábio Peixoto, Oren Smaletz, Fábio Schutz, Daniel Herchenhorn, Telma Santos, Flavio Mavignier Carcano, David Queiroz Muniz, Paulo R. S. Nunes Filho, Facundo Zaffaroni, Carlos Barrios and André Fay BMC Cancer